Literature DB >> 32096053

Dementia Therapy Targeting Tau.

Luc Buee1.   

Abstract

Tau is a microtubule-associated tau proteins but it has also non-microtubular functions. It aggregates in Alzheimer's disease and many neurodegenerative disorders referred to as tauopathies. Such aggregation may result from mutations on the tau gene, MAPT, dysregulation in alternative splicing, post-translational modifications or truncation. This final chapter addresses some of the various researches on a therapeutic potential around the tau protein and its gene, MAPT. Many therapeutic strategies are ongoing but they are hampered by the lack of knowledge on tau physiological functions.

Entities:  

Year:  2019        PMID: 32096053     DOI: 10.1007/978-981-32-9358-8_30

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Systematic analysis to identify transcriptome-wide dysregulation of Alzheimer's disease in genes and isoforms.

Authors:  Cong Fan; Ken Chen; Jiaxin Zhou; Ping-Pui Wong; Dan He; Yiqi Huang; Xin Wang; Tianze Ling; Yuedong Yang; Huiying Zhao
Journal:  Hum Genet       Date:  2020-11-02       Impact factor: 4.132

2.  The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice.

Authors:  Jing Di; Ibrar Siddique; Zizheng Li; Ghattas Malki; Simon Hornung; Suman Dutta; Ian Hurst; Ella Ishaaya; Austin Wang; Sally Tu; Ani Boghos; Ida Ericsson; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan
Journal:  Alzheimers Res Ther       Date:  2021-01-04       Impact factor: 8.823

3.  Microtubule-associated protein tau in murine kidney: role in podocyte architecture.

Authors:  Laura Vallés-Saiz; Rocio Peinado-Cahuchola; Jesús Ávila; Félix Hernández
Journal:  Cell Mol Life Sci       Date:  2022-01-27       Impact factor: 9.261

4.  Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice.

Authors:  Tao Yang; Harry Liu; Kevin C Tran; Albert Leng; Stephen M Massa; Frank M Longo
Journal:  Acta Neuropathol Commun       Date:  2020-09-05       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.